Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a.

Liang C, Chen W, Zhi X, Ma T, Xia X, Liu H, Zhang Q, Hu Q, Zhang Y, Bai X, Liang T.

Mol Cancer. 2013 Feb 19;12:14. doi: 10.1186/1476-4598-12-14.

2.

Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.

Wang J, Zheng X, Zeng G, Zhou Y, Yuan H.

Int J Mol Med. 2014 Feb;33(2):441-8. doi: 10.3892/ijmm.2013.1587. Epub 2013 Dec 12.

PMID:
24337611
3.

Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.

Wang JG, Zheng XX, Zeng GY, Zhou YJ, Yuan H.

Oncol Rep. 2014 Jan;31(1):488-96. doi: 10.3892/or.2013.2855. Epub 2013 Nov 15.

PMID:
24247909
4.

Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.

He L, Yang X, Cao X, Liu F, Quan M, Cao J.

Oncol Rep. 2013 Jan;29(1):103-8. doi: 10.3892/or.2012.2076. Epub 2012 Oct 9.

PMID:
23064420
5.

Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.

Fei M, Lu M, Wang Y, Zhao Y, He S, Gao S, Ke Q, Liu Y, Li P, Cui X, Shen A, Cheng C.

Med Oncol. 2009;26(2):178-85. doi: 10.1007/s12032-008-9105-8. Epub 2008 Oct 21.

PMID:
18937079
6.

FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.

Ceballos MP, Parody JP, Quiroga AD, Casella ML, Francés DE, Larocca MC, Carnovale CE, Alvarez Mde L, Carrillo MC.

J Interferon Cytokine Res. 2014 Nov;34(11):858-69. doi: 10.1089/jir.2013.0124. Epub 2014 Jun 20.

7.

Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.

Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, Ng TT, Karadedou CT, Millour J, Ip YC, Cheung YN, Sunters A, Chan KY, Lam EW, Khoo US.

PLoS One. 2010 Aug 20;5(8):e12293. doi: 10.1371/journal.pone.0012293.

8.

Interferon-β gene-modified human bone marrow mesenchymal stem cells attenuate hepatocellular carcinoma through inhibiting AKT/FOXO3a pathway.

Xie C, Xie DY, Lin BL, Zhang GL, Wang PP, Peng L, Gao ZL.

Br J Cancer. 2013 Sep 3;109(5):1198-205. doi: 10.1038/bjc.2013.422. Epub 2013 Jul 25.

9.

Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.

Xu D, He X, Chang Y, Xu C, Jiang X, Sun S, Lin J.

Oncol Rep. 2013 Feb;29(2):653-61. doi: 10.3892/or.2012.2138. Epub 2012 Nov 14.

PMID:
23151657
10.

Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a.

Xie C, Song LB, Wu JH, Li J, Yun JP, Lai JM, Xie DY, Lin BL, Yuan YF, Li M, Gao ZL.

PLoS One. 2012;7(7):e40607. doi: 10.1371/journal.pone.0040607. Epub 2012 Jul 16.

11.

Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.

Yang LJ, Tang Q, Wu J, Chen Y, Zheng F, Dai Z, Hann SS.

J Exp Clin Cancer Res. 2016 Mar 31;35:59. doi: 10.1186/s13046-016-0330-2. Erratum in: J Exp Clin Cancer Res. 2016;35:81.

12.

Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells.

Carbajo-Pescador S, Steinmetz C, Kashyap A, Lorenz S, Mauriz JL, Heise M, Galle PR, González-Gallego J, Strand S.

Br J Cancer. 2013 Feb 5;108(2):442-9. doi: 10.1038/bjc.2012.563. Epub 2012 Dec 20.

13.

Simvastatin induces growth inhibition and apoptosis in HepG2 and Huh7 hepatocellular carcinoma cells via upregulation of Notch1 expression.

Huang X, Ma J, Xu J, Su Q, Zhao J.

Mol Med Rep. 2015 Mar;11(3):2334-40. doi: 10.3892/mmr.2014.2976. Epub 2014 Nov 19.

PMID:
25412322
14.
15.

Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.

Huang W, Chen Z, Zhang L, Tian D, Wang D, Fan D, Wu K, Xia L.

Gastroenterology. 2015 Oct;149(4):1053-67.e14. doi: 10.1053/j.gastro.2015.05.058. Epub 2015 Jun 9.

PMID:
26065367
16.

Resveratrol induces apoptosis through modulation of the Akt/FoxO3a/Bim pathway in HepG2 cells.

Liu MH, Lin XL, Li J, He J, Tan TP, Wu SJ, Yu S, Chen L, Liu J, Tian W, Chen YD, Fu HY, Yuan C, Zhang Y.

Mol Med Rep. 2016 Feb;13(2):1689-94. doi: 10.3892/mmr.2015.4695. Epub 2015 Dec 18.

PMID:
26709007
17.

DJ-1 knockdown inhibits growth and xenograft‑induced tumor generation of human hepatocellular carcinoma cells.

Liu S, Long G, Wei H, Shi L, Yang Z, Liu D, Hu G, Qiu H.

Oncol Rep. 2015 Jan;33(1):201-6. doi: 10.3892/or.2014.3594. Epub 2014 Nov 7.

PMID:
25384406
18.

FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.

Shukla S, Rizvi F, Raisuddin S, Kakkar P.

Free Radic Biol Med. 2014 Nov;76:185-99. doi: 10.1016/j.freeradbiomed.2014.07.039. Epub 2014 Aug 13.

PMID:
25128467
19.

FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells.

Liu H, Yin J, Wang C, Gu Y, Deng M, He Z.

Anticancer Drugs. 2014 Sep;25(8):898-907. doi: 10.1097/CAD.0000000000000117.

PMID:
24814195
20.

Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.

Wu WL, Wang WY, Yao WQ, Li GD.

Int J Mol Med. 2015 Dec;36(6):1713-9. doi: 10.3892/ijmm.2015.2379. Epub 2015 Oct 16.

PMID:
26499886

Supplemental Content

Support Center